Cuffless blood pressure technologies continue to advance rapidly across wearable monitoring and digital health applications. However, innovative sensing alone is not sufficient for regulatory success. Sponsors must generate regulator-ready clinical evidence demonstrating that device measurements are accurate, traceable, and supported by transparent methodology. What Is Regulator-Ready Clinical Evidence? Regulator-ready evidence refers to clinical data prepared for formal F

Cuffless blood pressure devices may need to demonstrate performance not only during stable conditions, but also as blood pressure changes. Change testing evaluates whether a device can accurately respond to increases and decreases in blood pressure under controlled clinical conditions. For certain cuffless technologies and calibration approaches, blood pressure change testing is an important component of the validation strategy. Why Change Testing Matters Cuffless devices

Cuffless blood pressure technologies are rapidly expanding across wearable monitoring, remote physiological monitoring, and digital health applications. However, validating these systems requires carefully designed clinical studies capable of addressing the unique challenges associated with algorithm-driven blood pressure estimation. Study design decisions directly influence data quality, regulatory outcomes, and overall validation success. Why Cuffless Validation Is Differ

Blood Pressure Device Validation Studies Accurate blood pressure measurement is fundamental to physiological monitoring. As new technologies expand beyond traditional cuffs into wearable and cuffless blood pressure devices, sponsors must demonstrate performance using a structured blood pressure validation study. These studies evaluate how closely a device’s measurements align with reference measurements obtained through established clinical methods and generate the evidence r

A Familiar Framework with Important Regulatory Implications In January 2026, the FDA released a draft guidance titled “ Cuffless Non-Invasive Blood Pressure Measuring Devices – Clinical Performance Testing and Evaluation .” The document outlines FDA’s current recommendations on how cuffless blood pressure (BP) devices—both intermittent and continuous—should be clinically evaluated to support premarket submissions. For developers already working in this space, the guidance

Introduction Cuffless blood pressure (BP) monitoring has become a major focus in wearable and medical device innovation. Unlike...